McKesson, Cardinal, AmerisourceBergen could be on hook for $21B opioid settlement

Maia Anderson –
Wednesday, November 4th, 2020
Print|Email.

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this material? View our policies by click on this link.

McKesson, Cardinal Health and AmerisourceBergen may need to pony up $21 billion to settle countless opioid suits, The Hill reported Nov. 3..

Check out the full post here..

The lawsuits accuse the 3 pharma giants of deceptively marketing opioids and overlooking caution signs that opioids were being diverted for unsuitable use, according to The Hill..

In its quarterly report, Mckesson said it might pay about $8 billion of the overall settlement over the next 18 years. The company was initially set to pay $6.68 billion in a settlement structure proposed last year..

Last October, the 3 business proposed a combined $18 billion settlement to resolve about 3,200 suits, Johnson & & Johnson had actually likewise consented to pay an additional $4 billion, but after pushback from regional and state federal governments, the drugmaker in October accepted pay $5 billion..

More short articles on pharmacy: Gilead must quit FDA coupon for remdesivir, client supporters sayMylan, Pfizer get federal OK for merger with UpjohnMissouri drugmaker newest to recall metformin over carcinogen.

McKesson stated settlement negotiations are continuous, The Hill reported..